Hudson Biotech
Clinical trials sponsored by Hudson Biotech, explained in plain language.
-
Could a mitochondrial peptide help reverse prediabetes?
Disease control Recruiting nowThis study tests an investigational drug called MOTS-c in 120 adults with prediabetes and overweight or obesity. The goal is to see if 12 weeks of treatment can improve how the body uses insulin, compared to a placebo. All participants also receive standard lifestyle advice. The …
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug TB-500 aims to improve blood vessel health in heart disease patients
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called TB-500 in 80 adults with stable atherosclerotic cardiovascular disease. The main goal is to see if the drug is safe and tolerable. Researchers will also measure changes in blood vessel function and inflammation as earl…
Phase: PHASE1, PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Weekly shot shows promise for major weight loss in obesity trial
Disease control Recruiting nowThis study tests a once-weekly injection called tirzepatide in about 2,500 adults with obesity or overweight who do not have type 2 diabetes. Participants receive either the drug or a placebo, along with diet and exercise advice. The main goal is to see how much weight they lose …
Phase: PHASE3 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug shows promise in shrinking fatty liver
Disease control Recruiting nowThis study tests whether a daily injection of tesamorelin can safely reduce liver fat in adults with metabolic fatty liver disease (MASLD). About 120 participants will receive either the drug or a placebo for 52 weeks, along with lifestyle advice. The main goal is to measure chan…
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New weekly shot shows promise for major weight loss in obesity trial
Disease control Recruiting nowThis study tests a new once-weekly injection called retatrutide (LY3437943) to help people with obesity or overweight who also have weight-related health problems like high blood pressure or high cholesterol. About 300 adults will receive either the drug or a placebo, along with …
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New peptide injection could get athletes back in the game faster
Disease control Recruiting nowThis study tests whether a daily injection of BPC 157, a synthetic peptide, can help people with a moderate hamstring tear heal faster. 120 adults aged 18-45 with a recent MRI-confirmed grade II strain will receive either BPC 157 or a placebo for 14 days, plus standard rehab. The…
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a hormone drug help restore skin color in vitiligo?
Disease control Recruiting nowThis Phase 2 study tests whether adding Melanotan II (a synthetic hormone-like drug) to standard narrowband UV-B light therapy helps restore skin color in adults with stable nonsegmental vitiligo. About 60 participants will receive either the drug or a placebo, plus light therapy…
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Copper gel shows promise for faster wound healing in new trial
Symptom relief Recruiting nowThis study tests a topical gel containing GHK-Cu, a copper-peptide complex, to see if it can safely speed up healing of small, standardized skin wounds in healthy adults. Sixty participants will each get two small wounds on their arm; one wound gets the active gel, the other a pl…
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC